Kenneth Frazier, chief executive officer of Merck pharmaceutical company, is stepping down from his post. It was announced that he will be leaving his post in June, and Robert Davis, the current chief financial officer, is set to take over.
Merck welcomes new CEO as Frazier leaves post
Frazier has been with Merck for 29 years years, and he is one of the few African Americans to lead a major firm included in Fortune 500 companies. With his retirement that was announced on Feb. 4, only three Black CEOs will remain.
“On behalf of the entire Merck board, I thank Ken for his strong and highly principled leadership and his commitment to the company’s core values of scientific excellence, business integrity, patient focus and respect for all people,” Les Brun, Merck's lead independent director, said via press release. “Ken’s vision and courage to make difficult changes within Merck, while steadfastly investing in research and development, have positioned Merck well for sustainable future growth.”
Starting July 1, Robert Davis will be Merck’s new chief, and he said that his appointment is such a great honor. He joined the company as the CFO in 2014. Frazier stated that the company’s board and himself are delighted to have Davis as the next CEO. The outgoing chief described his successor as someone with “deep knowledge of our company and industry who was also a highly capable finance leader.”
Frazier’s future plans
The retiring chief has been leading the company since 2011, although he first joined Merck in 1992. At that time, he worked in the public affairs division as general counsel, and in 1999, he was named senior general counsel.
Fox Business reported that the 66-year-old Kenneth Frazier, 66, will continue to be part of Merck’s board as executive chairman once he steps down from his post. He will be staying for the duration of the transition period.
He was originally set to retire in 2019, but Merck discarded its policy that says CEOs must leave at the age of 65. The son of a janitor worked his way to the top and led the pharmaceutical firm to greater success when he took over 10 years ago.
In any case, Frazier revealed that once he leaves Merck, he plans to do public service but explained that this doesn’t mean he will run for government office. CNBC noted He did not say what exactly he will do but admitted that he has been receiving a lot of offers. He also co-chairs an initiative called OneTen, which strives to help create jobs and opportunities for Black Americans.
“I care very much about issues of equity and justice, particularly around education,” he said. “The thing I care most about is opportunity.”


Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Asia FX Weekly Gains Hold Amid U.S. Inflation Data and Iran Ceasefire Uncertainty
Trump Claims Oil Tankers Heading to U.S. Amid Iran War and Strait of Hormuz Crisis
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase
Meta Is Building an AI Version of Mark Zuckerberg to Interact With Employees
U.S. Futures Slip as Iran Ceasefire Uncertainty and CPI Data Weigh on Markets
AI Deradicalization Tools: How Chatbots Could Help Combat Violent Extremism Online
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Trump Slams Iran Over Strait of Hormuz Oil Restrictions Amid Fragile Ceasefire
Federal Reserve Probes Big Banks Over Private Credit Exposure Amid Growing Systemic Risk Concerns
Bank of America Maintains Forecast for Two Fed Rate Cuts in 2026 Despite Inflation Risks
Asia FX Slides as Dollar Surges Amid U.S.-Iran Tensions and Inflation Fears
BCA Research Warns U.S.-Iran Ceasefire Could Collapse, Maintains Cautious Equity Outlook 



